http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 06 Mar 2026 06:04:00 +0000 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++QUALIF+++++VIVOS+INC++++++++++++++++++++++++++++/26121799.html si-local-file:///var/storage/secattach/20260306/26121799.html http://www.streetinsider.com/SEC+Filings/Form++QUALIF+++++VIVOS+INC++++++++++++++++++++++++++++/26121799.html Fri, 06 Mar 2026 06:04:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++QUALIF+++++VIVOS+INC++++++++++++++++++++++++++++/26121799.html si-local-file:///var/storage/secattach/20260306/26121799.html http://www.streetinsider.com/SEC+Filings/Form++QUALIF+++++VIVOS+INC++++++++++++++++++++++++++++/26121799.html Fri, 06 Mar 2026 06:04:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++1-AA++++++VIVOS+INC++++++++++++++++++++++++++++/26109242.html si-local-file:///var/storage/secattach/20260304/26109242.html http://www.streetinsider.com/SEC+Filings/Form++1-AA++++++VIVOS+INC++++++++++++++++++++++++++++/26109242.html Wed, 04 Mar 2026 11:49:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++1-AA++++++VIVOS+INC++++++++++++++++++++++++++++/26109242.html si-local-file:///var/storage/secattach/20260304/26109242.html http://www.streetinsider.com/SEC+Filings/Form++1-AA++++++VIVOS+INC++++++++++++++++++++++++++++/26109242.html Wed, 04 Mar 2026 11:49:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++1-A++++++++VIVOS+INC++++++++++++++++++++++++++++/26005155.html si-local-file:///var/storage/secattach/20260217/26005155.html http://www.streetinsider.com/SEC+Filings/Form++1-A++++++++VIVOS+INC++++++++++++++++++++++++++++/26005155.html Tue, 17 Feb 2026 06:12:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++1-A++++++++VIVOS+INC++++++++++++++++++++++++++++/26005155.html si-local-file:///var/storage/secattach/20260217/26005155.html http://www.streetinsider.com/SEC+Filings/Form++1-A++++++++VIVOS+INC++++++++++++++++++++++++++++/26005155.html Tue, 17 Feb 2026 06:12:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+31++Filed+by%3A+Korenko+Michael+K/25797012.html si-local-file:///var/storage/secattach/20260102/25797012.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+31++Filed+by%3A+Korenko+Michael+K/25797012.html Fri, 02 Jan 2026 11:06:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+31++Filed+by%3A+Korenko+Michael+K/25797012.html si-local-file:///var/storage/secattach/20260102/25797012.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+31++Filed+by%3A+Korenko+Michael+K/25797012.html Fri, 02 Jan 2026 11:06:00 +0000 O.03791480 RDGL http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Press+Releases/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html <p align="justify">Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking access to IsoPet therapy, signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. Starting in Q1 2026, the division will implement profitability-focused initiatives while continuing to expand its network of certified clinics.</p> <p align="justify">Over 100 IsoPet treatments have been safely http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Summarizes+Progress+in+its+Animal+Therapy+Division/25769678.html Mon, 22 Dec 2025 12:56:00 +0000 A.12763360 O.03791480 O.20319167 RDGL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+02++Filed+by%3A+Korenko+Michael+K/25718057.html si-local-file:///var/storage/secattach/20251209/25718057.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+02++Filed+by%3A+Korenko+Michael+K/25718057.html Tue, 09 Dec 2025 16:01:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+02++Filed+by%3A+Korenko+Michael+K/25718057.html si-local-file:///var/storage/secattach/20251209/25718057.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Dec+02++Filed+by%3A+Korenko+Michael+K/25718057.html Tue, 09 Dec 2025 16:01:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Nov+20++Filed+by%3A+Korenko+Michael+K/25645827.html si-local-file:///var/storage/secattach/20251120/25645827.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Nov+20++Filed+by%3A+Korenko+Michael+K/25645827.html Thu, 20 Nov 2025 19:34:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Nov+20++Filed+by%3A+Korenko+Michael+K/25645827.html si-local-file:///var/storage/secattach/20251120/25645827.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++VIVOS+INC+++++++++++++++++For%3A+Nov+20++Filed+by%3A+Korenko+Michael+K/25645827.html Thu, 20 Nov 2025 19:34:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++VIVOS+INC+++++++++++++++++For%3A+Sep+30/25591449.html si-local-file:///var/storage/secattach/20251112/25591449.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++VIVOS+INC+++++++++++++++++For%3A+Sep+30/25591449.html Wed, 12 Nov 2025 06:08:00 +0000 O.03791480 RDGL http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++VIVOS+INC+++++++++++++++++For%3A+Sep+30/25591449.html si-local-file:///var/storage/secattach/20251112/25591449.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++VIVOS+INC+++++++++++++++++For%3A+Sep+30/25591449.html Wed, 12 Nov 2025 06:08:00 +0000 O.03791480 RDGL http://www.streetinsider.com/Press+Releases/Vivos+Inc+Board+Authorizes+Vivios+Inc+to+Establish+a+Corporate+Entity+in+India/25388645.html <p align="justify">Kennewick, WA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL)</p> <p align="justify">The Vivos Board granted authorization to form a wholly owned corporate subsidiary in India. Vivos Inc filed for the name of Vivos Scientific India LLP. Vivos is completing the steps remaining to obtain formal approvals from the Indian government.</p> <p align="justify">“This demonstrates our long-term commitment to doing business in India and supports our long-term plan of establishing our first international manufacturing center for RadioGel and IsoPet, for expanding our developmental animal testing, and for commercially treating humans and animals in India.”</p> http://www.streetinsider.com/Press+Releases/Vivos+Inc+Board+Authorizes+Vivios+Inc+to+Establish+a+Corporate+Entity+in+India/25388645.html Mon, 29 Sep 2025 08:30:00 +0000 O.03791480 RDGL http://www.streetinsider.com/Press+Releases/Vivos+Inc+Board+Authorizes+Vivios+Inc+to+Establish+a+Corporate+Entity+in+India/25388645.html <p align="justify">Kennewick, WA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL)</p> <p align="justify">The Vivos Board granted authorization to form a wholly owned corporate subsidiary in India. Vivos Inc filed for the name of Vivos Scientific India LLP. Vivos is completing the steps remaining to obtain formal approvals from the Indian government.</p> <p align="justify">“This demonstrates our long-term commitment to doing business in India and supports our long-term plan of establishing our first international manufacturing center for RadioGel and IsoPet, for expanding our developmental animal testing, and for commercially treating humans and animals in India.”</p> http://www.streetinsider.com/Press+Releases/Vivos+Inc+Board+Authorizes+Vivios+Inc+to+Establish+a+Corporate+Entity+in+India/25388645.html Mon, 29 Sep 2025 08:30:00 +0000 O.03791480 RDGL http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Board+Authorizes+Vivios+Inc+to+Establish+a+Corporate+Entity+in+India/25388645.html <p align="justify">Kennewick, WA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL)</p> <p align="justify">The Vivos Board granted authorization to form a wholly owned corporate subsidiary in India. Vivos Inc filed for the name of Vivos Scientific India LLP. Vivos is completing the steps remaining to obtain formal approvals from the Indian government.</p> <p align="justify">“This demonstrates our long-term commitment to doing business in India and supports our long-term plan of establishing our first international manufacturing center for RadioGel and IsoPet, for expanding our developmental animal testing, and for commercially treating humans and animals in India.”</p> http://www.streetinsider.com/Globe+Newswire/Vivos+Inc+Board+Authorizes+Vivios+Inc+to+Establish+a+Corporate+Entity+in+India/25388645.html Mon, 29 Sep 2025 08:30:00 +0000 O.03791480 RDGL